DEINOVE announces its participation in the large & Midcap event

MONTPELLIER, France, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Deinove (Alternext Paris: ALDEI), a cleantech company that designs and develops new industrial production standards based on the Deinococcus bacteria, announces today that it will participate in the "Large & Midcap Event", organized by CF&B Communication. This event will take place on October 2^nd & 3^rd, in Paris, France.

On this occasion, Emmanuel Petiot, CEO of DEINOVE, will present the Company, its development strategy and its latest news, in one-to-one meetings.

DEINOVE is committed to meet on a regular basis with the financial community. Investors can also find updated information on the Company's website (www.deinove.com) and contact the investor relations team by writing to coralie.martin@deinove.com.

About DEINOVE

DEINOVE (Alternext Paris: ALDEI) is changing the green chemistry domain by designing and developing new bioproduction standards based on bacteria of yet untapped potential: the  Deinococci. By taking advantage of their singular genetic properties and their unusual robustness, DEINOVE optimizes the metabolic and fermentative capacities of these natural "micro-factories" to create high value-added products from non-food biomass. The Company's primary markets are 2^nd generation biofuels (DEINOL) and alternative chemical compounds for petroleum-derived products (DEINOCHEM), in which DEINOVE offers its technology to global industrial partners. Listed on Alternext since April 2010, DEINOVE was founded by Dr. Philippe Pouletty, CEO of Truffle Capital, and Pr. Miroslav Radman, from the Faculty of Medicine at Université René Descartes. The company employs more than 40 people in its new laboratories in Montpellier, France, at the Biopôle Euromédecine center.

More information at www.deinove.com

Contacts

pr DEINOVE announces its participation http://hugin.info/142979/R/1859992/651851.pdf

HUG#1859992